The Effects of Technologically Advanced Running Shoes on Lower Extremity Joint Contact Forces in Trained Female Runners

Summary

Running in “supershoes” can help people run faster, but we do not fully know how they affect loads in the lower limb. This study will look at how these shoes and different running speeds change loading at the ankle, knee and hips in a group of high level recreational runners. What we learn could help make running shoes safer and better designed for runners.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 45

Accepts healthy participants: Yes

Inclusion criteria:

We are looking for:
1) Recreational female and male runners, aged 18-45 years of age
2) Shoe size US women's 7-9, US men's 9-11
3) Within the previous 12 months, have completed one of the following:
a) Females: a half marathon in under 1 hour 52 min, a 10-km race in under 49 min, or a 5-km race in under 23 min;
b) Males: a half marathon in under 1 hour 40 min, a 10-km race in under 45 min, or a 5-km race in under 21 min;
4) No prior history of foot injury requiring surgery
5) No lower-limb injuries within the past 6 months
6) Able to read and write in English and provide informed consent

Exclusion criteria:

1) Prospective participants who are pregnant are not eligible to participate in this research.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Colin Firminger

Principal investigator:

William Brent Edwards

Clinical trial:

No

REB-ID:

REB25-1141